Lipoprotein(a) [Lp(a)] is a unique lipoprotein that has emerged as an independent risk factor for cardiovascular vascular disease. Data from case control, epigenetic and mendelian randomization studies indicate that people with elevated Lp(a) have a two-fold to four-fold increased risk of cardiovascular events compared to people with low Lp(a) levels. Despite this risk, awareness of Lp(a) is still very low among health care providers. Even cardiologists often overlook Lp(a), in part because Lp(a) is not as well-understood as other risk factors and treatment options are still very limited.

This book offers an authoritative and comprehensive overview of Lipoprotein(a). It provides an in-depth review of all aspects of Lp(a), from pathophysiology to metabolism. Chapters offer the reader a contemporary view of the important roles of Lp(a) as a risk factor for cardiovascular disease. In addition, this volume discusses the clinical implications of elevated Lp(a) and current and future therapies.

Lipoprotein(a) is an essential resource for physicians, medical students, residents, fellows, and allied health professionals in lipidology, cardiology, endocrinology, pharmacotherapy, and health promotion and disease prevention.

Autorentext

Karam Kostner, MD, Ph.D., FRACP, FCSANZ Associate Professor of Medicine

University of Queensland and Mater Hospital Brisbane, Australia

Gerhard M. Kostner, Ph.D. Emeritus Professor of Biochemistry and Molecular Biology

Medical University of Graz, Austria Graz, Austria

Peter P. Toth, M.D. , PhD, FAHA, FESC, FACC

Adjunct Professor of Medicine

Division of Cardiology

Johns Hopkins University School of Medicine

Baltimore, Maryland USA